Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Immune cells affect hair growth and could lead to new hair loss treatments.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Human hair follicles have a scent receptor that can influence hair growth.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

People with alopecia have a higher risk of thyroid cancer.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Chronic stress can cause hair loss by increasing oxidative stress, but antioxidants may help.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.